Phd in DATA SCIENCE

email: marianna.maranghi@uniroma1.it
phone: 3929091560
building: II clinics medica IV piano

Europass
Curriculum Vitae

Personal information
First name(s) / Surname(s) Marianna Maranghi
Work Address(es)
Residence Adress 155 Viale del Policlinico, 00166, Rome, Italy.
19, via G. Sacconi, lotto F scala B, 00196 Rome , Italy
Telephone(s) Mobile: +39 392 9091560
E-mail marianna.maranghi@uniroma1.it ; mariannamaranghi@yahoo.it

Nationality Italian

Date, city and state of birth 08/02/1976 Rome Italy

Gender Female

Current employer
Date since employed Occupational field




Current employer
Data since employed
Occupational Field

Sapienza University of Rome, Italy
December 2011
Associate Professor in Internal Medicine – Research and Clinical Coordinator of the Diabetes and Cardiovascular Prevention Clinic SMSC01 Internal Medicine G- Policlinico Umberto I Hospital, Rome

Azienda Policlinico Umberto I- Rome
April 2015
Medical Assistant at the Department of Internal Medicine and Medical Specialties – Outpatient Diabetes and Cardiovascular Prevention Clinic and Inpatient Internal Medicine Department SMSC01

Work experience


Dates From March 2010 to May 2011
Occupation or position held Post doctoral Research position at Sapienza University Rome
Main activities and responsibilities Coordination of the clinical outpatient activities and of cardiovascular non-invasive diagnostics in type 2 diabetes
Name and address of employer Outpatients department for Diabetes and Endocrinology,Internal Medicine and Medical Specialties Department Policlinico Umberto I Hospital – Sapienza University, Rome
Type of business or sector University hospital

Dates From January 2009 to February 2010
Occupation or position held Post-doctoral Research Fellow at the Department of Internal Medicine- University of Helsinki Biomedicum- working on a project entitled ”Diabetic dyslipidemia and metabolic control” under the supervision of Professor Marjia Riitta Taskinen
Main activities and responsibilities Researcher
Name and address of employer Professor M.R. Taskinen
Type of business or sector Internal Medicine
Dates From February 2007 to December 2009
Occupation or position held Medical director, grade 1
Main activities and responsibilities Coordination of the Cardiovascular Prevention Clinic Policlinico Umberto I Rome
Name and address of employer Department of Clinical Science - Policlinico Umberto I Hospital– Sapienza University, Rome

Type of business or sector University hospital

Last ICH-GCP training:may 2019; Prov; ider Novonordisk

Clinical Trials Novo Nordisk-NN2211-1860
2008-2010 The Effect of Liraglutide Compared to Sitagliptin,
Both in Combination With Metformin in Subjects With Type 2 Diabetes
Bayer-ARRIVE
2008-2014 Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Novo Nordisk-NN1250-3582
2008-2010 Efficacy and Safety of NN1250 and Insulin Glargine in
Subjects With Type 2 Diabetes Currently Treated With Insulin Qualifying for Intensified Treatment
Novo Nordisk-12503667
2009-2011 An Extension Trial to NN1250-3582 Comparing Safety
and Efficacy of NN1250 and Insulin Glargine in Type 2 Diabetes
Novartis-CLAF237B2224
2008-2010 Efficacy and Long-Term Safety of Vildagliptin as Add-on
Therapy to Metformin in Patients With Type 2 Diabetes
Merck-MK0431.102
2009-2010 Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus
NovoNordisk-EX2211-3748
2010-2016 Liraglutide Effect on Cardiovascular Events
Merck-MK0431.403
2011-2012 Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a Liraglutide-Based Treatment Paradigm in Patients With Type 2 Diabetes Mellitus
Merck-MK0431.260
2012-2013 To Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus
Novartis-CLAF237A 23156
2015- Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus
Novo Nordisk-1250-3944
2012-2013 The Effect of Insulin Degludec in Combination With Liraglutide and
Metformin in Subjects With Type 2 Diabetes
Merck-MK3102-018
2013-2016 Study to Assess Cardiovascular Outcomes With MK-3102 in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk-NN9535-3624
2013-2015 Efficacy and safety of semaglutide once-weekly versus exenatide ER 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes
Novo Nordisk-NN9924-3790
2013-2014 Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide (NNC0113-0217) in subjects with type 2 diabetes
Novo Nordisk-EX1250-4080
2014-2016 A trial comparing cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events
Novonordisk
EX9924-4473 2019- Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes
Novo Nordisk-NN9924-3790
2013-2014 Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide (NNC0113-0217) in subjects with type 2 diabetes





Degrees

Dates

Title of qualification awarded 2011

Master degree in Diabetology
Name and type of organisation providing education and training Sapienza University , Rome

Dates 2005-2008
Title of qualification awarded Ph.D. Degree in Biomedical Technologies and Clinical Medicine
Name and type of organisation
Providing education and training


Sapienza University , Rome
Dates 2008
Title of qualification awarded NLA Master in Lipidology Advanced Training and Board Review Course
Name and type of organization providing education and training National Lipid Association

Dates 2000 – 2005
Title of qualification awarded Board in Internal Medicine
Name and type of organisation providing education and training Sapienza University , Rome

Dates 1994 - 2000
Title of qualification awarded Master Degree in Medicine and Surgery
Name and type of organisation providing education and training Sapienza University, Rome

Dates 1989 – 1994
Title of qualification awarded High School Leaving Qualification with specialization in Classical studies
Name and type of organisation providing education and training Liceo Ginnasio Statale Dante Alighieri di Roma




Awards and Honors

Dates



Dates





Umberto Di Mario Foundation” Prize.

2005

Marcello Santoro Prize, SISA Foundation

2012
Membership of Scientific-Professional Societies







Teaching activities


Dates





Dates
















Personal skills and competences Italian Internal Medicine Society
Italian society for the study of atherosclerosis
European Atherosclerosis Society








2007-2014
Internal Medicine III
“A“ Course of Medicine Sapienza University

2015-2016
Internal Medicine III
B Course of Medicine Sapienza University



2013-ongoing
Internal Medicine in Geriatrics
Undergraduate Physiotheraphy Course
S. Giovanni Addolorata
Sapienza University

2016-ongoing
Internal Medicine and Surgey III
F Course of Medicine Sapienza University

2018-ongoing
AMSM1
F Course of Medicine Sapienza University



Mother tongue(s)
Italian
Other language(s) English
Self-assessment
European level (*) Understanding Speaking Writing
English Listening Reading Spoken interaction Spoken production
A1 A1 A1 A1 A1
(*) Common European Framework of Reference for Languages

Computer skills and competences Good working knowledge of the Internet and e-mail tools, as well as of the Office Package both in Windows and Mac OS, mainly used for the following purposes: to draft scientific articles and documentation; to process statistical data with Excel sheets and SPSS software and to create presentations for conferences and academic lessons.

Driving licence B

Additional information
Voluntary Work












Scientific Pubblications  2011 Good and clinical practice (GCP) course
 2001 Three months voluntary fellow at the Laboratory of the Department of Clinical Pharmacology – Trinity College Dublin under the supervision of Professor D. Fitzgerald.
 2006 One month voluntary clinical working experience at the Center for Human Nutrition – The University of Texas, Southwestern Medical Center (Dallas, USA) under the supervision of Professor N. Abate.
 Sailing instructor at Centro Velico Caprera Sailing School Italy









Pubbli1. a.
2. Grani G, Lamartina L, Ramundo V, Falcone R, Lomonaco C, Ciotti L, Barone M, Maranghi M,Cantisani V, Filetti S, Durante C.Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS Systems. Eur Thyroid J. 2020 Feb;9(2):85-91. doi: 10.1159/000504219. Epub 2019 Nov

3. Grani G, Brenta G, Trimboli P, Falcone R, Ramundo V, Maranghi M, Lucia P, Filetti S, Durante C Sonographic Risk Stratification Systems for Thyroid Nodules as Rule-Out Tests in Older Adults.Cancers (Basel). 2020 Aug 30;12(9):2458. doi: 10.3390/


4. D'Erasmo L, Commodari D, Di Costanzo A, Minicocci I, Polito L, Ceci F, Montali A, Maranghi M, Arca M. Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational study.Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):2027-2035.
5. Lenzi A, Maranghi M, Stilo G, Velardi P. The social phenotype: Extracting a patient-centered perspective of diabetes from health-related blogs.Artif Intell Med. 2019 Nov;101:101727. doi: 10.1016/j.artmed.2019.101727. Epub 2019 Oct 24.

6. Rodríguez-Rodríguez I, Chatzigiannakis I, Rodríguez JV, Maranghi M,
a. Gentili M, Zamora-Izquierdo MÁ.Utility of Big Data in Predicting Short-Term Blood Glucose Levels in Type 1 Diabetes Mellitus Through Machine Learning Techniques.Sensors (Basel). 2019 Oct 16;19(20). pii: E4482.

7. Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg SØ, Lingvay I, Søndergaard AL, Treppendahl MB, Montanya E; PIONEER 2 Investigators Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial.Diabetes Care. 2019 Sep 17. pii: dc190883. doi: 10.2337/dc19-0883.

8. Grani G, Tumino D, Ramundo V, Ciotti L, Lomonaco C, Armillotta M, Falcone R, Lucia P, Maranghi M, Filetti S, Durante C.
a. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.J Endocrinol Invest. 2019 Jun 15. doi: 10.1007/s40618-019-01074-x.

9. Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11.

10. Celano M, Maggisano V, Lepore SM, Sponziello M, Pecce V, Verrienti A, Durante C, Maranghi M, Lucia P, Bulotta S, Damante G, Russo D.Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells.
a. Int J Endocrinol. 2019 Feb 14;2019:5031696. doi: 10.1155/2019/5031696. eCollection 2019.


11. Lai C, Filippetti G, Schifano I, Aceto P, Tomai M, Lai S, Pierro L, Renzi A, Carnovale A, Maranghi M.
a. Psychological, emotional and social impairments are associated with adherence and healthcare spending in type 2 diabetic patients: an observational study. Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):749-754. doi: 10.26355/eurrev_201901_16889.

12. Ramundo V, Lamartina L, Falcone R, Ciotti L, Lomonaco C, Biffoni M, Giacomelli L, Maranghi M, Durante C, Grani G.
a. Is thyroid nodule location associated with malignancy risk?Ultrasonography. 2019 Jul;38(3):231-235. doi: 10.14366/usg.18050. Epub 2018 Nov 6.

13. Maggisano V, Celano M, Lepore SM, Sponziello M, Rosignolo F, Pecce V, Verrienti A, Baldan F, Mio C, Allegri L, Maranghi M, Falcone R, Damante G, Russo D, Bulotta S.Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.
a. Endocrine. 2019 Mar;63(3):545-553. doi: 10.1007/s12020-018-01836-2. Epub 2019 Jan 19.

14. Maranghi M, Truglio G, Gallo A, Grieco E, Verrienti A, Montali A, Gallo P, Alesini F, Arca M, Lucarelli M.A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
a. Biochem Biophys Res Commun. 2019 Jan 8;508(2):487-493. doi: 10.1016/j.bbrc.2018.11.064. Epub 2018 Nov 30.

15. Lamartina L, Montesano T, Falcone R, Biffoni M, Grani G, Maranghi M, Ciotti L, Giacomelli L, Ramundo V, Lomonaco C, Di Gioia CR, Piernatale L, Ronga G, Durante C IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?Endocr Pract. 2019 Feb;25(2):165-169. doi: 10.4158/EP-2018-0393. Epub 2018 Nov 1. Erratum in: Endocr Pract. 2019 Apr;25(4):401.

16. Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, Maranghi M, Falcone R, Ramundo V, Cantisani V, Filetti S, Durante C.Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS.J Clin Endocrinol Metab. 2019 Jan 1;104(1):95-102. doi: 10.1210/jc.2018-01674.

17. Grani G, Lamartina L, Montesano T, Ronga G, Maggisano V, Falcone R, Ramundo V, Giacomelli L, Durante C, Russo D, Maranghi M. Lack of association between obesity and aggressiveness of differentiated thyroid cancer.J Endocrinol Invest. 2018 Apr 17.

18. Grani G, Lamartina L, Cantisani V, Maranghi M, Lucia P, Durante C.Interobserver agreement of various thyroid imaging reporting and data systems.Endocr Connect. 2018 Jan;7(1):1-7. IF 2.541

19. Pirillo A, Garlaschelli K, Arca M, Averna M, Bertolini S, Calandra S, Tarugi P, Catapano AL; LIPIGEN Group.Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.Atheroscler Suppl. 2017 Oct;29:17-24.


20. Averna M, Cefalù AB, Casula M, Noto D, Arca M, Bertolini S, Calandra S, Catapano AL, Tarugi P; LIPIGEN Group.Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN).Atheroscler Suppl. 2017 Oct;29:11-16.

21. Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Aug 31;377(9):839-848.


22. Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.N Engl J Med. 2017 Aug 24;377(8):723-732.

23. Gallo A, Giral P, Carrié A, Carreau V, Béliard S, Bittar R, Maranghi M, Arca M, Cluzel P, Redheuil A, Bruckert E, Rosenbaum D. Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia. J Clin Lipidol. 2017 May - Jun;11(3):704-711 IF 5.812

24. Di Costanzo A, D'Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, Loffredo L, Perri L, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Catalano C, Maranghi M, Del Ben M, Angelico F, Arca M. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. Atherosclerosis. 2017 Feb;257:232-239.

25. Lamartina L, Montesano T, Trulli F, Attard M, Torlontano M, Bruno R, Meringolo D, Monzani F, Tumino S, Ronga G, Maranghi M, Biffoni M, Filetti S, Durante C. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients. Endocrine. 2016 Nov;54(2):467-475.

26. Cohen O, Filetti S, Castañeda J, Maranghi M, Glandt M. When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump. Diabetes Care. 2016 Aug;39 Suppl 2:S180-6.

27. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee.; LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):311-22


28. Lamartina L, Grani G, Biffoni M, Giacomelli L, Costante G, Lupo S, Maranghi M, Plasmati K, Sponziello M, Trulli F, Verrienti A, Filetti S, Durante C. Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2016 Aug;101(8):3036-44.

29. Minicocci I, Tikka A, Poggiogalle E, Metso J, Montali A, Ceci F, Labbadia G, Fontana M, Di Costanzo A, Maranghi M, Rosano A, Ehnholm C, Donini LM, Jauhiainen M, Arca M. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. J Lipid Res. 2016 Jun;57(6):1097-107.

30. Verrienti A, Carbone A, Bellitti P, Fabiano MC, De Rose RF, Maranghi M, Lucia P, Durante C, Rosignolo F, Pecce V, Sponziello M, Puppin C, Costante G, Bruno R. A novel double mutation val648ile and val804leu of ret proto-oncogene in multiple endocrine neoplasia type 2. Endocr Pract. 2015 Aug 6.

31. Montali A, Truglio G, Martino F, Ceci F, Ferraguti G, Ciociola E, Maranghi M, Gianfagna F, Iacoviello L, Strom R, Lucarelli M, Arca M.Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects. PLoS One. 2015 Jul 15;10(7).


32. Maranghi M, Carnovale A, Durante C, Tarquini G, Tiseo G, Filetti S.Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes.
a. Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):125-37. doi: 10.1517/17425255.2015.986457. Epub 2014 Nov 24.

33. Barbarossa G, Renzi A, D'Erasmo L, Gallo A, Grieco E, Rossetti M, Carnovale A, Santilli M, Mandosi E, Coletta P, Pergolini D, Morano S, Maranghi M. The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward? Diabetes Res Clin Pract. 2014 Jan 8. pii: S0168-8227(14)00022-9. doi: 10.1016/j.diabres.2013.12.061. IF 3.639

34. Minicocci I, Santini S, Cantisani V, Stitziel N, Kathiresan S, Arroyo JA, Martí G, Pisciotta L, Noto D, Cefalù AB, Maranghi M, Labbadia G, Pigna G, Pannozzo F, Ceci F, Ciociola E,Bertolini S, Calandra S, Tarugi P, Averna M, Arca M. Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. J Lipid Res. 2013 Dec;54(12):3481-90.

35. Arca M, Minicocci I, Maranghi M. The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism. Curr Opin Lipidol. 2013 Aug;24(4):313-20

36. Robciuc MR*, Maranghi M*, Lahikainen A, Rader D, Bensadoun A, Oorni K, Metso J, Minicocci I, Montali A, Ciociola E, Ceci F, Arca M, Ehnholm C, Jauhiainen M. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity and decreased serum free fatty acids . Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1706-13

37. Minicocci I, Cantisani V, Poggiogalle E, Favari E, Zimetti F, Montali A, Labbadia G, Pigna G, Pannozzo F, Zannella A, Ceci F, Ciociola E, Santini S, Maranghi M. Vestri AR, Ricci P, Bernin F, Arca M. Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysis. Int J Cardiol. 2013 Oct 9;168(4):4375-8

38. Kaye SM, Maranghi M, Bogl LH, Kaprio J, Hakkarainen A, Lundbom J, Lundbom N, Rissanen A, Taskinen MR, Pietiläinen KH.Acquired liver fat is a key determinant of serum lipid alterations in healthy monozygotic twins. Obesity (Silver Spring). 2012 Dec 12. IF 3.873


39. Coletta P., Barbarossa G., Pergolini D., D'Erasmo L, Renzi A., Mercuri L., Anatra M. G., Ciociola E, Verrienti A, Maranghi M Genetic determinants and early carotid atherosclerosis: is there a role for the ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP-1) K121Q polymorphism? Preliminary results in non diabetic individuals. Endocrine. 2012 Dec;42(3):749-51.

40. Maranghi M, Prudente S, D'Erasmo L, Morini E, Ciociola E, Coletta P, Verrienti A, Arciello S, Copetti M, Pellegrini F, Santini SA, Morano S, Filetti S, Trischitta V.The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals. Nutr Metab Cardiovasc Dis. 2012 Mar 6.

41. Yetukuri L, Huopaniemi I, Koivuniemi A, Maranghi M, Hiukka A, Nygren H, Kaski S, Taskinen MR, Vattulainen I, Jauhiainen M, Orešič M. High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy. PLoS One. 2011;6(8):e23589.


42. Bogl LH, Maranghi M, Rissanen A, Kaprio J, Taskinen MR, Pietiläinen KH. Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study. Atherosclerosis. 2011 Dec;219(2):880-6.



43. Maranghi M, Hiukka A, Badeau R, Sundvall J, Jauhiainen M, Taskinen MR. Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy. Atherosclerosis. 2011 Nov;219(1):259-65.

44. Mastroianno S, Torlontano M, Scillitani A, D'Aloiso L, Verrienti A, Bonfitto N, De Bonis A, D'Agruma L, Muscarella LA, Guarnieri V, Dicembrino F, Maranghi M, Durante C, Filetti S. Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family. Endocrine. 2011 Dec;40(3):481-5.

45. Durante C, Tallini G, Puxeddu E, Sponziello M, Moretti S, Ligorio C, Cavaliere A, Rhoden KJ, Verrienti A, Maranghi M, Giacomelli L, Russo D, Filetti S. BRAF V600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. Eur J Endocrinol. 2011 Sep;165(3):455-63.

46. Irace C, Rossetti M, Carallo C, Morano S, Vespertini V, Mandosi E, Maranghi M, Fiorentino R, Filetti S, Gnasso A. Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes. Acta Diabetol. 2011 Feb 9.

47. Colotto M, Maranghi M, Durante C, Rossetti M, Renzi A, Anatra MG. PFAPA syndrome in a young adult with a history of tonsillectomy. Intern Med. 2011;50(3):223-5. Epub 2011 Feb 1.

48. Sponziello ML, Bruno R, Durante C, D'Agostino M, Corradino R, Giannasio P, Ciociola E, Ferretti E, Maranghi M, Verrienti A, De Toma G, Filetti S, Russo D. Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression. Horm Metab Res. 2011 Jan;43(1):22-5.

49. Hiukka A, Maranghi M, Matikainen N, Taskinen MR. PPARalpha: an emerging therapeutic target in diabetic microvascular damage.Nat Rev Endocrinol. 2010 Aug;6(8):454-63. Epub 2010 Jun 22. Review. Erratum in: Nat Rev Endocrinol. 2010 Sep;6(9):476

50. Castellone MD, Verrienti A, Magendra Rao D, Sponziello M, Fabbro D, Muthu M, Durante C, Maranghi M, Damante G, Pizzolitto S, Costante G, Russo D, Santoro M, Filetti S. A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization. Clin Endocrinol (Oxf). 2010 Oct;73(4):529-34.

51. Maranghi M, Pugliese F, Cianci R, Colotto M, Durante C, Anatra MG, Coletta P, Mercuri S, Rossetti M, Morano S, Filetti S. Atherosclerosis renal artery stenosis and in-stent restenosis in a diabetic patient: Targeting on diabetic dyslipidemia is a key intervention.J Endocrinol Invest. 2010 Apr;33(4):284-5.

52. Sponziello M, Scipioni A, Durante C, Verrienti A, Maranghi M, Giacomelli L, Ferretti E, Celano M, Filetti S, Russo D. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. J Endocrinol Invest. 2010 Jan;33(1):2-6.

53. Gatti A, Maranghi M, Bacci S, Carallo C, Gnasso A, Mandosi E, Fallarino M, Morano S, Trischitta V, Filetti S.Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes. Diabetes Care. 2009 Aug;32(8):1550-2. IF 11.857


54. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007, 92(2): 450-5.

55. Ronga G, Bruno R, Puxeddu E, Calcinaro F, Montesano T, Travascio L, Colandrea M, Durante C, Maranghi M, Filetti S, Russo D. Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia. Thyroid. 2007, 17(4): 363-6.

56. Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Al- Nahhas A, Rubello D, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer. Biomedicine & Pharmacotherapy 2007, 61(8): 468-71 .


57. Maranghi M, Coletta P, Durante C, Pergolini D, Filetti S. Malattia cardiovascolare e sindrome metabolica: oggi e domani. Recenti Progressi in Medicina. 2006, 97 (12): 719-26.

58. Romagnoli E, Carnevale V, Calandra P, D'Erasmo E, De Geronimo S, Pepe J, Manfredi G, Maranghi M, Aliberti G, Minisola S. Impact of fractures on health care in a major university hospital in Rome. Aging Clin Exp Res. 2003, 15(6): 505-11.

59. Romagnoli E, Carnevale V, Nofroni I, D'Erasmo E, Paglia F, De Geronimo S, Pepe J, Raejntroph N, Maranghi M, Minisola S.: Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures.
Osteoporos Int. 2004, 15(12): 975-80.

60. Filetti S, Durante C, Maranghi M. A genetic based disease management in inherited cancer syndromes: the multiple endrocrine neoplasia model. Supportive & Palliative Cancer Care. 2006, 2 (suppl. 2): 13-16.

61. Durante C, Romagnoli E, Maranghi M, D’Aloiso L, Minisola S, D’Erasmo E, Filetti S. Hyperparathyroidism in multiple endocrine neoplasia type IIA. Clinical Cases in Mineral and Bone Metabolism. 2006, 3 (2): 162-6.

62. Violi F, Loffredo L, Maranghi M. Effect of vitamins E and C on transplant-associated atherosclerosis. Lancet. 2002, 360 (9331): 486.


63. Iuliano L, Micheletta F, Maranghi M, Frati G, Diczfalusy U, Violi F Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol. 2001, 21 (10): E34-7.

64.

I declare under full personal responsibility that the information contained in the present CV are true and accurate.

Rome, 21..dec.2020